ArticleCancer medicine2020

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma.

Zhi-Ming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.